Saturday, December 3, 2022

561.316.3330

Biotechnology News Magazine

Atarraya and BiomEdit Announce Research Collaboration to Increase Sustainability of Shrimp Farming and Improve Global Food Security

Sustainable shrimp farming startup Atarraya partners with microbiome startup BiomEdit to research novel approaches in aquaculture shrimp production via improvements in microbial ecosystems

Latest Posts

Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia

Venetoclax is a BCL-2 inhibitor approved by the U.S. Food and Drug Administration (FDA) for treatment of several hematologic cancers, including in combination with azacytidine for elderly patients with AML unable to tolerate the standard of care.

Acer Therapeutics Announces $1.5M Private Placement

The proceeds from the private placement will be used by Acer Therapeutics for working capital and general corporate purposes and, together with Acer’s existing cash and cash equivalents, are expected to be sufficient to fund the Company’s anticipated operating and capital requirements through the fourth quarter of 2022.

AC Immune’s Alzheimer’s Disease Vaccine-candidate ACI-35.030 Selected for Further Development

Dr. Andrea Pfeifer, CEO of AC Immune SA, commented: “The selection of ACI-35.030 for further development is a significant step for this collaboration. Early clinical testing showed that ACI-35.030 was generally well tolerated and induced specific activity against the pathological species of Tau, including the neurotoxic pTau and enriched paired helical filaments (ePHF) species, both of which are closely implicated in Alzheimer’s disease (AD).

TransCode Therapeutics Announces eIND Submission to US FDA for Planned First-in-Human Clinical Trial in Patients with Advanced Solid Tumors

The planned clinical trial is to evaluate TransCode’s lead therapeutic candidate, TTX-MC138, in cancer patients with advanced solid tumors. ​TTX-MC138 is designed to inhibit the pro-metastatic RNA, microRNA-10b, described as the master regulator of metastasis in a number of advanced solid tumors. TransCode Therapeutics believes that TTX-MC138 could be used as a treatment for many of these cancers.

Atarraya Inc, creator of Shrimpbox, the first sustainable ‘plug-and-play’ shrimp farming technology, and BiomEdit, a microbiome innovator focused on animal health, today announced a research collaboration to investigate microbial changes to improve the cost-effectiveness, sustainability and production output associated with shrimp farming.

The research partnership will focus on nitrifying microbes and vibriosis control, and will study how microbial communities change over time in a shrimp biofloc system to define the homeostasis of the ecosystem created for sustainable shrimp farming.

The goal of Atarraya and BiomEdit’s research collaboration is to gain a better understanding of microbial communities and their correlation with nitrogen spikes and other environmental changes. The knowledge gained from the study will help to minimize water usage, improve the environmental footprint of production and reduce the amount of feed needed to produce shrimp. This will improve the cost-effectiveness of sustainable shrimp farming significantly as feed is responsible for about 50% of shrimp production cost.

“Our collaboration with BiomEdit goes back to the core idea of Atarraya: using deep science knowledge to optimize protein production and contribute to global food security,” said Daniel Russek, CEO and founder of Atarraya. “The findings from this research project will help Atarraya to increase the production output of shrimp farming while reducing costs and improving sustainability. Together, we are making shrimp the most sustainable protein choice in global food production.”

Atarraya and BiomEdit expect to learn more about the ecosystem in aquaculture by using advanced microbiological tools to analyze the composition and diversity of microorganisms that inhabit the shrimp pond, as well as their interactions with each other and their environment.

“The Microbiome project will allow a deeper understanding of the role of the microbial community in maintaining crop homeostasis,” explains André Freitas, Biotech Director, Atarraya Inc. “The future of modern aquaculture is based on the use of innovative technology applied to high productivity systems, rational use of water and production of premium quality protein. Shrimp farming in a biofloc system is the face of this new aquaculture.”

Atarraya’s shrimp farming technology uses biofloc technology to transform waste nutrients into feed with the help of microorganisms. As part of the research collaboration, BiomEdit will use its gene-sequencing platform to provide critical insights into the roles of various microorganisms in the growth cycle of shrimp through high-throughput strain isolation and characterization. The approach is especially critical in land-based aquaculture systems with low environmental impact and increases the reliability of shrimp protein production. The research findings will be used to inspire strategies that optimize the health and performance of aquaculture shrimp production.

As one of the most popular proteins in the world, shrimp plays a key role in feeding a growing global population. In the past five years, shrimp sales volume increased from 275 to 415 million pounds. Yet, conventional methods of shrimp farming are disastrous for the environment – destroying seabeds and polluting oceans. Housed in a traditional shipping container, Shrimpbox by Atarraya is the key to meeting the growing demand for shrimp by increasing production while minimizing the impact on the planet.

“We are pleased to collaborate with Atarraya to find new ways to unlock the potential of the microbiome for shrimp producers who are trying to increase production and reduce their environmental footprint to meet the demands of a growing population,” said Aaron Schacht, CEO of BiomEdit. “Our deep knowledge in the microbiome in livestock paired with Atarraya’s immense expertise in shrimp and aquaculture production systems form an ideal match to optimize the use of biofloc.”

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine